Literature DB >> 18750309

Internal medicine: use of ipratropium bromide in chronic obstructive pulmonary disease.

D P Tashkin.   

Abstract

The Scientific Board of the California Medical Association presents the following inventory of items of progress in internal medicine. Each item, in the judgment of a panel of knowledgeable physicians, has recently become reasonably firmly established, both as to scientific fact and important clinical significance. The items are presented in simple epitome, and an authoritative reference, both to the item itself and to the subject as a whole, is generally given for those who may be unfamiliar with a particular item. The purpose is to assist busy practitioners, students, research workers or scholars to stay abreast of these items of progress in internal medicine that have recently achieved a substantial degree of authoritative acceptance, whether in their own field of special interest or another.The items of progress listed below were selected by the Advisory Panel to the Section on Internal Medicine of the California Medical Association and the summaries were prepared under its direction.

Entities:  

Year:  1987        PMID: 18750309      PMCID: PMC1025859     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  5 in total

1.  A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence.

Authors:  P A Easton; C Jadue; S Dhingra; N R Anthonisen
Journal:  N Engl J Med       Date:  1986-09-18       Impact factor: 91.245

2.  Role of the parasympathetic system in airway obstruction due to emphysema.

Authors:  N J Gross; M S Skorodin
Journal:  N Engl J Med       Date:  1984-08-16       Impact factor: 91.245

Review 3.  Anticholinergic, antimuscarinic bronchodilators.

Authors:  N J Gross; M S Skorodin
Journal:  Am Rev Respir Dis       Date:  1984-05

4.  Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis.

Authors:  I M Lightbody; C G Ingram; J S Legge; R N Johnston
Journal:  Br J Dis Chest       Date:  1978-07

5.  Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study.

Authors:  D P Tashkin; K Ashutosh; E R Bleecker; E J Britt; D W Cugell; J M Cummiskey; L DeLorenzo; M J Gilman; G N Gross; N J Gross
Journal:  Am J Med       Date:  1986-11-14       Impact factor: 4.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.